BeStock  
Stocks › LBRX

LB Pharmaceuticals LBRX

US equityMarket cap rank #3171
$34.16 −$0.10 (-0.29%)
Pre-market · Oct 8, 7:30 am ET · After hours $34.16 0.00%
Open$34.02
Prev close$34.26
Day range$34.00 – $36.57
Volume385.0K
Market cap$1.10B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 4 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-14.3%BearishTrading below the 20-day average of $39.84
Price vs 50-day average-22.1%BearishTrading below the 50-day average of $43.84
Price vs 200-day average+9.7%BullishTrading above the 200-day average of $31.13
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)26.0NeutralOversold territory (30 or below); selling this heavy often eases
MACD (12,26,9)-2.64BearishMACD line is below its signal line
Bollinger band position12%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$39.84-14.3%
50-day SMA$43.84-22.1%
200-day SMA$31.13+9.7%

Recent price levels

LevelPrice
20-day high$47.68
20-day low$33.73
60-day high$50.16
60-day low$29.36
Upper Bollinger band$47.32
Lower Bollinger band$32.36

The 50-day average is currently 40.8% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility44.4%
Average true range5.77% of price
Max drawdown (1y)-31.0%
Volume (10d vs 90d)1.34x

Discussion

No comments yet — be the first to weigh in on LBRX.

Leave a comment

Scroll to Top